<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ICVX
Icosavax
$
()


  • option delistings on March 19th

    3/19/2024 - 08:30am
  • Icosavax just downgraded at Guggenheim, here's why

    1/2/2024 - 04:53am
  • What You Missed On Wall Street On Tuesday

    12/12/2023 - 16:14pm
  • Icosavax just downgraded at Jefferies, here's why

    12/12/2023 - 14:57pm
  • Icosavax just downgraded at William Blair, here's why

    12/12/2023 - 12:40pm
  • What You Missed On Wall Street This Morning

    12/12/2023 - 12:00pm
  • Fly Intel: Pre-market Movers

    12/12/2023 - 09:03am
  • Icosavax announces interim results from IVX-A12 trial

    12/12/2023 - 05:39am
  • Icosavax to be acquired by AstraZeneca for $15.00 per share in cash, CVR

    12/12/2023 - 05:35am
  • Icosavax initiated with a Buy at Guggenheim

    11/17/2023 - 06:29am
  • Icosavax reports Q3 EPS (44c), consensus (57c)

    11/14/2023 - 16:13pm
  • Icosavax reports Q2 EPS (59c), consensus (60c)

    8/14/2023 - 16:32pm
  • Icosavax reports immunogenicity data on VLP vaccine IVX-121 for RSV

    8/8/2023 - 17:17pm
  • Icosavax initiates Phase 2 trial of IVX-A12 against RSV, hMPV

    6/20/2023 - 08:14am
  • Icosavax sells 8.37M shares at $8.10 in registered direct offering

    5/22/2023 - 17:55pm
dynamic_feed Breaking News